{"id":"W2001379228","doi":"10.1158/1535-7163.targ-13-a247","title":"Abstract A247: BT2111, a new anticancer agent composed of trastuzumab and transcend a vector for brain delivery for the treatment of metastatic Her2+ breast cancer.","year":2013,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; Institute for Biological Sciences","funders":"","keywords":"Trastuzumab; Medicine; Parenchyma; Monoclonal antibody; Breast cancer; Antibody; Confocal microscopy; Blood–brain barrier; Intracardiac injection; Pathology; Metastatic breast cancer; Cancer research; Pharmacology; Cancer; Internal medicine; Immunology; Central nervous system; Biology; Cell biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005269235,0.0001949553,0.0003905029,0.00002250732,0.0000673563,0.00001264996,0.00009461905,0.00005043031,0.0001429299],"category_scores_gemma":[0.000002855468,0.0001344976,0.0002191369,0.0001115792,0.000164732,0.00002595786,0.000003764898,0.00005929714,3.429302e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001167755,"about_ca_system_score_gemma":0.0002467733,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005209703,"about_ca_topic_score_gemma":0.00002512627,"domain_scores_codex":[0.9990551,0.00001384976,0.0003162899,0.0002266332,0.0001579165,0.000230244],"domain_scores_gemma":[0.9991053,0.0002627587,0.0001231418,0.000236006,0.000143952,0.0001288094],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006491393,0.0005336942,0.0001415914,0.0004921878,0.001456005,0.000001269392,0.0005624787,0.0001729241,0.8612769,0.00009828131,0.0001642093,0.1344513],"study_design_scores_gemma":[0.009398106,0.0007959239,0.01329442,0.0001885309,0.003291705,0.00001960372,0.0002708125,0.007816912,0.9376363,0.0003073339,0.02670533,0.0002750032],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9382994,0.02137282,0.01433081,0.02128845,0.00007089578,0.003652703,0.0009352056,0.00002079551,0.00002889466],"genre_scores_gemma":[0.9930863,0.003426668,0.001266443,0.000965482,0.00008464166,0.001014572,0.00001978537,0.00003474949,0.000101367],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1341763,"threshold_uncertainty_score":0.5484655,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05868971413243731,"score_gpt":0.3592567249271313,"score_spread":0.300567010794694,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}